| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 656 | 2022 |
| Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 BS Sheena, L Hiebert, H Han, H Ippolito, M Abbasi-Kangevari, ... The lancet Gastroenterology & hepatology 7 (9), 796-829, 2022 | 517 | 2022 |
| Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 D Bryazka, MB Reitsma, MG Griswold, KH Abate, C Abbafati, ... The Lancet 400 (10347), 185-235, 2022 | 380 | 2022 |
| Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ... The lancet Gastroenterology & hepatology 7 (7), 627-647, 2022 | 371 | 2022 |
| Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 F Farzadfar, M Naghavi, SG Sepanlou, SS Moghaddam, WJ Dangel, ... The Lancet 399 (10335), 1625-1645, 2022 | 205 | 2022 |
| The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 EM Alvarez, LM Force, R Xu, K Compton, D Lu, HJ Henrikson, ... The Lancet Oncology 23 (1), 27-52, 2022 | 179 | 2022 |
| Use of green spaces, self-satisfaction and social contacts in adolescents: A population-based CASPIAN-V study P Dadvand, S Hariri, B Abbasi, R Heshmat, M Qorbani, ME Motlagh, ... Environmental research 168, 171-177, 2019 | 108 | 2019 |
| Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era S Hariri, H Sharafi, M Sheikh, S Merat, F Hashemi, F Azimian, B Tamadoni, ... Harm Reduction Journal 17, 1-9, 2020 | 25 | 2020 |
| Prevalence and determinants of diabetes and prediabetes in southwestern Iran: the Khuzestan comprehensive health study (KCHS) S Hariri, Z Rahimi, N Hashemi-Madani, SA Mard, F Hashemi, ... BMC endocrine disorders 21, 1-11, 2021 | 23 | 2021 |
| A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low-to middle-income setting S Hariri, M Sharafkhah, M Alavi, G Roshandel, A Fazel, T Amiriani, ... Harm Reduction Journal 17, 1-9, 2020 | 17 | 2020 |
| The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories JV Lazarus, H Han, HE Mark, SA Alqahtani, JM Schattenberg, JB Soriano, ... Hepatology 78 (3), 911-928, 2023 | 15 | 2023 |
| Subjective Proximity to Green Spaces and Blood Pressure in Children and Adolescents: The CASPIAN‐V Study B Abbasi, M Pourmirzaei, S Hariri, R Heshmat, M Qorbani, P Dadvand, ... Journal of Environmental and Public Health 2020 (1), 8886241, 2020 | 15 | 2020 |
| The Khuzestan Comprehensive Health Study (KCHS): methodology and profile of participants B Cheraghian, M Sharafkhah, Z Mohammadi, S Hariri, Z Rahimi, ... Archives of Iranian medicine 23 (10), 653-657, 2020 | 12 | 2020 |
| Lead poisoning among asymptomatic individuals with a long-term history of opiate use in Golestan Cohort Study A Etemadi, S Hariri, H Hassanian-moghaddam, H Poustchi, G Roshandel, ... International Journal of Drug Policy 104, 103695, 2022 | 11 | 2022 |
| Prevalence of impaired renal function and determinants in the southwest of Iran S Alvand, F Abolnezhadian, S Alatab, Z Mohammadi, F Hayati, M Noori, ... BMC nephrology 22 (1), 276, 2021 | 10 | 2021 |
| Population‐based prevalence of polypharmacy and patterns of medication use in southwestern Iran: A cross‐sectional study E Taherifard, Z Mohammadi, H Molavi Vardanjani, M Pakroo, M Emaminia, ... Pharmacoepidemiology and Drug Safety 31 (5), 592-603, 2022 | 9 | 2022 |
| Incidence, early case fatality and determinants of stroke in Iran: Golestan cohort study N Motamed-Gorji, S Hariri, S Masoudi, M Sharafkhah, M Nalini, ... Journal of Stroke and Cerebrovascular Diseases 31 (10), 106658, 2022 | 3 | 2022 |
| The pattern of medication use, and determinants of the prevalence of polypharmacy among patients with a recent history of depressive disorder: results from the pars cohort study M Ghaed-Sharaf, S Hariri, H Poustchi, M Nourollahi, S Khani, E Taherifard, ... BMC psychology 10 (1), 12, 2022 | 3 | 2022 |
| An intervention to increase hepatitis C virus diagnosis and treatment uptake among people in custody in Iran S Hariri, M Alavi, G Roshandel, Z Mohammadi, A Fazel, T Amiriani, ... International Journal of Drug Policy 95, 103269, 2021 | 3 | 2021 |
| SARS-CoV-2 seroprevalence among health care workers in major private and public hospitals with COVID-19 patient's referral in Tehran, Iran M Darvishian, M Sharafkhah, Z Mohammadi, K Sadeghniiat-Haghighi, ... Frontiers in Public Health 10, 832003, 2022 | 2 | 2022 |